Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06133816
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2023-10-18
Brief Title:
Lung Cancer Screening Eligibility Assessment
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Study Overview
Official Title:
Using a Simplified Tool to Predict Lung Cancer Screening LCS Eligibility Experiment to Test Effects of Messaging on Response Rates
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey ie the simplified eligibility tool that is designed to estimate pack-year eligibility for lung cancer screening LCS This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS and expand upon survey methodology in general
Detailed Description:
Despite growing evidence that lung cancer screening LCS reduces lung cancer-specific mortality LCS across the United States is remarkably low This is due in part to challenges with identifying adults who meet eligibility criteria for lifetime smoking intensity ie 20 pack-years or greater which is often missing from the electronic medical record We have developed a simplified eligibility tool that has shown accuracy in estimating pack-years But given the potential for low response rates there is a great need to identify effective strategies to increasing response rates equitably prior to using it in practice or in future studies The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey ie the simplified eligibility tool that is designed to estimate pack-year eligibility for lung cancer screening LCS This will help to identify the best way to increase response rates to the tool in future intervention studies designed to increase LCS and expand upon survey methodology in general
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 850376 | OTHER | UPenn IRB | httpsreporternihgovquickSearchP50CA271338-02 |
| P50CA271338-02 | NIH | None | None |